Swiss Drug Maker, Novartis, In The Midst Of Dangerous Dilemmas
January 10, 2012
In the past two months, the Swiss drug maker, Novartis, has been plagued with problems ranging from deadly side effects of new drugs to dangerous mix-ups in the manufacturing and packaging of medications.
The reports began in December of 2011 when a 59-year-old multiple sclerosis patient dropped dead after taking his first dose of a trial medication, Gilenya. An article by Reuters said that the patient was monitored for six hours after taking the medication with no incident. The drug company stated that the drug is known to slow the heartbeat, but returns to normal after several hours. The investigation into determining the cause of death in the patient is still ongoing.
Just as the media attention surrounding the patient’s death began to die off, the company was broadsided by another harmful mistake, this time in the manufacturing of old drugs. 9 News Now reported yesterday that the company had recalled certain drugs in response to a mix-up at a Lincoln, Nebraska, manufacturing facility that may have accidentally packaged prescription painkillers into bottles of several over-the-counter medications. Officials believe that opioid painkillers, such as Percocet, Endocet, Opana and Zydone may have accidentally been packaged in bottles of Excedrin, Gas-X, Bufferin and NoDoz.
The Maryland drug injury lawyers with ChasenBoscolo would like to pass on the advice given by the drug’s manufacturer to confirm that all medications recently purchased are correctly packaged by comparing the pills in the bottle to the picture on the outside label.
Popularity: 1% [?]
Tags: chasenboscolo, DC Drug Injury Lawyer, Endocet, Endocet recall, Gilenya, Maryland Drug Injury Lawyer, Novartis, Opana, Percocet, Zydone